105-F

N/A

Report date: 2025/01/26 15:36:11

Base Information

Drug Name105-F
Drug Alias Namehuman multipotent cell conditioned media subfraction (Histogen/Histogen Oncology)human multipotent cell conditioned media subfraction (Histogen/Adaptive Biologix)105-F
ClassificationCell and gene therapy > Cell therapy
Mechanisms of ActionApoptosis stimulants
TargetsUpdating
Therapy Area/IndicationsPancreatic NeoplasmsMelanoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesHistogen Inc
China Registration ClassN/A

Develop Information

Active CompaniesAdaptive Biologix LLCHistogen Inc
Inactive CompaniesN/A
Active IndicationsPancreatic NeoplasmsMelanoma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A